tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Arcturus Therapeutics price target lowered to $9 from $12 at Citi
PremiumThe FlyArcturus Therapeutics price target lowered to $9 from $12 at Citi
3M ago
Arcturus Therapeutics: Promising Developments and Strong Financial Position Justify Buy Rating
Premium
Ratings
Arcturus Therapeutics: Promising Developments and Strong Financial Position Justify Buy Rating
3M ago
Arcturus Therapeutics Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Arcturus Therapeutics Earnings Call: Progress Amid Challenges
3M ago
Is ARCT a Buy, Before Earnings?
PremiumPre-EarningsIs ARCT a Buy, Before Earnings?
3M ago
Arcturus Therapeutics Advances Cystic Fibrosis Study with ARCT-032
Premium
Company Announcements
Arcturus Therapeutics Advances Cystic Fibrosis Study with ARCT-032
4M ago
Arcturus Therapeutics Advances with ARCT-810 Study for OTC Deficiency
Premium
Company Announcements
Arcturus Therapeutics Advances with ARCT-810 Study for OTC Deficiency
4M ago
Cathie Wood Loads Up on This Beaten-Down Biotech Stock
PremiumMarket NewsCathie Wood Loads Up on This Beaten-Down Biotech Stock
4M ago
LendingClub upgraded, Enphase Energy downgraded: Wall Street’s top analyst calls
Premium
The Fly
LendingClub upgraded, Enphase Energy downgraded: Wall Street’s top analyst calls
4M ago
Arcturus Therapeutics downgraded to Neutral from Buy at Citi
Premium
The Fly
Arcturus Therapeutics downgraded to Neutral from Buy at Citi
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100